EP3853354A4 - NK CELLS DERIVED FROM MONONUCLEAR CELLS - Google Patents

NK CELLS DERIVED FROM MONONUCLEAR CELLS Download PDF

Info

Publication number
EP3853354A4
EP3853354A4 EP19936966.1A EP19936966A EP3853354A4 EP 3853354 A4 EP3853354 A4 EP 3853354A4 EP 19936966 A EP19936966 A EP 19936966A EP 3853354 A4 EP3853354 A4 EP 3853354A4
Authority
EP
European Patent Office
Prior art keywords
cells
cell derived
mononuclear cell
mononuclear
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19936966.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3853354A1 (en
Inventor
Rohit Duggal
Ranjeet SINHA
Wenzhao Li
Jason ISAACSON
Karl MARQUEZ
Patrick Soon-Shiong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunitybio Inc
Original Assignee
Immunitybio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunitybio Inc filed Critical Immunitybio Inc
Publication of EP3853354A1 publication Critical patent/EP3853354A1/en
Publication of EP3853354A4 publication Critical patent/EP3853354A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2315—Interleukin-15 (IL-15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EP19936966.1A 2019-07-08 2019-07-08 NK CELLS DERIVED FROM MONONUCLEAR CELLS Pending EP3853354A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/040867 WO2021006875A1 (en) 2019-07-08 2019-07-08 Mononuclear cell derived nk cells

Publications (2)

Publication Number Publication Date
EP3853354A1 EP3853354A1 (en) 2021-07-28
EP3853354A4 true EP3853354A4 (en) 2022-04-20

Family

ID=74114919

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19936966.1A Pending EP3853354A4 (en) 2019-07-08 2019-07-08 NK CELLS DERIVED FROM MONONUCLEAR CELLS

Country Status (9)

Country Link
EP (1) EP3853354A4 (ja)
JP (2) JP7213976B2 (ja)
KR (1) KR20210080566A (ja)
CN (1) CN113166726A (ja)
AU (1) AU2019456283B2 (ja)
CA (1) CA3120695A1 (ja)
IL (1) IL283998A (ja)
SG (1) SG11202104339WA (ja)
WO (1) WO2021006875A1 (ja)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180355317A1 (en) * 2016-02-15 2018-12-13 Dong Hyuk Shin Method of culturing nk cells and kits containing medium addtions therefore

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102428173B (zh) * 2009-03-26 2014-07-30 细胞维护北欧制药公司 Nk细胞的扩增
RU2012127811A (ru) 2009-12-04 2014-01-10 Стем Селл Энд Ридженерэйтив Медсин Интернэшнл, Инк. Способ получения клеток-натуральных киллеров и дендритных клеток из человеческих эмбриональных гемангиобластов, полученных из стволовых клеток
AU2010347018A1 (en) 2010-02-24 2012-09-20 Ingo Schmidt-Wolf Method for the generation of a CIK cell and NK cell population
DK3327040T3 (da) 2010-09-21 2021-09-20 Altor Bioscience Corp Multimeriske opløselige il-15-fusionsmolekyler og fremgangsmåder til at fremstille og anvende samme
US20130295671A1 (en) 2011-01-21 2013-11-07 Biotherapy Institute Of Japan Method for producing nk cell-enriched blood preparation
WO2012128622A1 (en) 2011-03-18 2012-09-27 Ipd-Therapeutics B.V. Generation of nk cells and nk-cell progenitors
PL2812011T3 (pl) 2012-02-08 2020-06-29 Glycostem Therapeutics B.V. Różnicowanie komórek NK z komórek hematopoetycznych CD34<sup>+</sup> ex vivo
CN102988415B (zh) 2012-08-15 2014-11-19 中航（宁夏）生物有限责任公司 人异基因有核细胞工业化制备自然杀伤性细胞(nk)及注射液
US11773364B2 (en) 2014-04-28 2023-10-03 Vivabiocell S.P.A. Automated cell culturing and harvesting device
EP3515471A4 (en) * 2016-09-23 2020-07-01 The Regents of The University of California SELF-MODIFIED LENTIVIRAL-MODIFIED IRRADIATED WHOLE CELL ANTI-TUMOR VACCINES TO EXPRESS CD80, IL-15 AND THE IL-15 ALPHA RECEPTOR
WO2018071919A1 (en) 2016-10-14 2018-04-19 Xencor, Inc. IL15/IL15Rα HETERODIMERIC FC-FUSION PROTEINS
EP3589316A1 (en) * 2017-02-28 2020-01-08 Affimed GmbH Combination of an anti-cd16a antibody with a cytokine
CN110785435B (zh) 2017-03-06 2024-01-23 艾尔特生物科技公司 与il-12和il-18的基于il-15的融合物
WO2018209208A1 (en) * 2017-05-11 2018-11-15 Nantkwest, Inc. Anti-egfr/high affinity nk-cells compositions and methods for chordoma treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180355317A1 (en) * 2016-02-15 2018-12-13 Dong Hyuk Shin Method of culturing nk cells and kits containing medium addtions therefore

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HONG-RAE LEE ET AL: "Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody", SCIENTIFIC REPORTS, vol. 7, no. 1, 11 September 2017 (2017-09-11), XP055762396, DOI: 10.1038/s41598-017-09259-1 *

Also Published As

Publication number Publication date
EP3853354A1 (en) 2021-07-28
AU2019456283B2 (en) 2023-06-08
WO2021006875A1 (en) 2021-01-14
JP2023040184A (ja) 2023-03-22
KR20210080566A (ko) 2021-06-30
JP2022513614A (ja) 2022-02-09
SG11202104339WA (en) 2021-05-28
AU2019456283A1 (en) 2021-05-20
CA3120695A1 (en) 2021-01-14
JP7213976B2 (ja) 2023-01-27
CN113166726A (zh) 2021-07-23
IL283998A (en) 2021-07-29

Similar Documents

Publication Publication Date Title
EP3830888A4 (en) NEGATIVE ELECTRODES FOR ELECTROCHEMICAL CELLS
EP4033544A4 (en) PHOTOVOLTAIC MODULE WITH DISC CELLS
EP4004201A4 (en) SINGLE CELL ANALYSIS
EP3904278A4 (en) SOLID ELECTROLYTE MATERIAL AND BATTERY WITH IT
EP3639316A4 (en) PRISMATIC STACKED ARCHITECTURE FOR ELECTROCHEMICAL CELL
EP3690992A4 (en) CATHODE FOR FIXED ELECTROLYTE BATTERY AND WITH FIXED ELECTROLYTE BATTERY
EP3890060A4 (en) ELECTRODE, CELL AND CELL PACK
EP3644423A4 (en) ELECTROCHEMICAL CELL AND ELECTROCHEMICAL STACK
EP3912202A4 (en) SOLVENT-FREE ELECTROCHEMICAL CELLS
EP3846266A4 (en) FUEL CELL BATTERY
EP3895239A4 (en) CATHODE FOR SOLID OXIDE FUEL CELL
EP3893285A4 (en) SOLAR CELL
EP3706195A4 (en) BATTERY CELL AND BATTERY CELL STACK
EP3662524A4 (en) ENHANCED ELECTROCHEMICAL ELEMENTS FOR USE IN A HIGH ENERGY BATTERY
EP3958336A4 (en) SOLAR CELL
EP3805383A4 (en) ANTIFIBROSIS COMPOSITION, CELLS PRODUCING THESE CELLS AND CELL LAYER CONTAINING THESE CELLS
EP3934007A4 (en) ELECTROCHEMICAL CELL MODULE
EP3499617A4 (en) SINGLE ELECTROCHEMICAL REACTION CELL, AND STACK OF ELECTROCHEMICAL REACTION CELLS
EP3879591A4 (en) SOLAR CELL
EP3925285A4 (en) DEFINITION OF KNOWN CELL WITH BEAMFORMING
EP3588644A4 (en) ELECTROCHEMICAL REACTION UNIT AND STACKING OF ELECTROCHEMICAL REACTION CELLS
EP3853354A4 (en) NK CELLS DERIVED FROM MONONUCLEAR CELLS
EP3890045A4 (en) ELECTROCHEMICAL CELL
EP3866248A4 (en) BATTERY CELL
EP4073849A4 (en) ALIGNED METALLIZATION FOR SOLAR CELLS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210421

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IMMUNITYBIO, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20220322

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/0783 20100101AFI20220316BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)